Skip to main content
Signal8

Hendricks Diane

SEC insider (Form 3/4/5 filer). CIK 0001727478. 10% Owner at Monopar Therapeutics (MNPR). 1 reported Form 4/5 transaction since Sep 2024; latest on Dec 16, 2025. Located in WILMETTE, IL.

Companies Hendricks Diane has filed insider reports for

  • Monopar Therapeutics (MNPR): 10% Owner
Hendricks Diane profile photo

Hendricks Diane

CIK: 0001727478

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (100.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Monopar Therapeutics logo
MNPR

Monopar Therapeutics

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • Monopar Therapeutics logo
    MNPR

    Monopar Therapeutics

    Dec 16, 2025
    Other
    Indirect
    43.5K shares-

1-1 of 1